Belite Bio (BLTE) Retained Earnings (2020 - 2025)
Belite Bio (BLTE) posted quarterly Retained Earnings of -$536000.0 for Q4 2025, up 99.5% year-over-year from -$268668.9 in Q4 2024, and up 99.66% quarter-over-quarter from -$159.9 million in Q3 2025.
Belite Bio (BLTE) Retained Earnings (2020 - 2025) Analysis & Trends
Belite Bio's Retained Earnings history runs 6 years deep, the most recent figure standing at -$536000.0 for Q4 2025.
- In Q4 2025, Retained Earnings rose 99.5% year-over-year to -$536000.0; the TTM figure through Dec 2025 stood at -$536000.0 (up 99.5% YoY), while the FY2025 annual figure was -$536000.0, up 99.5% from the prior year.
- Retained Earnings for Q4 2025 stood at -$536000.0, up from -$159.9 million in the prior quarter.
- The five-year high for Retained Earnings was -$196000.0 in Q4 2021, with the low at -$159.9 million in Q3 2025.
- The 5-year median for Retained Earnings is -$55.7 million (2022), against an average of -$63.3 million.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 20242.35% in 2022, then soared 99.5% in 2025.
- Belite Bio's Retained Earnings stood at -$196000.0 in 2021, then plunged by 20242.35% to -$39.9 million in 2022, then slumped by 79.34% to -$71.5 million in 2023, then tumbled by 50.55% to -$107.6 million in 2024, then jumped by 99.5% to -$536000.0 in 2025.
- Business Quant data shows BLTE's Retained Earnings at -$536000.0 in Q4 2025, -$159.9 million in Q3 2025, and -$107.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -536,000.00 |
| Sep 30, 2025 | -159.93 Mn |
| Dec 31, 2024 | -107.65 Mn |
| Dec 31, 2023 | -71.50 Mn |
| Dec 31, 2022 | -39.87 Mn |
| Dec 31, 2021 | -196,000.00 |
| Dec 31, 2020 | -17.60 Mn |